Evidence map›Paper›PMID 32009609›Full record

ReviewThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2020

Inborn errors of metabolism in the differential diagnosis of fatty liver disease.

Yılmaz Yıldız, Hatice Serap Sivri

Open access · bronzeAbstract readReview
In one paragraph

Review in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. MASLD In Children - A Distinct Phenotype?Current obesity reports · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2022
    Article
  7. Movement Disorders and Liver Disease.Movement disorders clinical practice · 2021
    Review
  8. Article
  9. Review
  10. Lean NAFLD: Do We Need to Lean-in Deeper to Manage it Better?Journal of clinical and experimental hepatology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yılmaz YıldızPediatric Metabolic Diseases Unit, Dr. Sami Ulus Training and Research Hospital for Maternity and Children's Health and Diseases, Ankara, Turkey.
Hatice Serap SivriDivision of Metabolic Diseases, Department of Pediatrics, Hacettepe University School of Medicine, Ankara, Turkey.
Hacettepe University · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease across all age groups. Obesity, diabetes, and metabolic syndrome, are the primary causes that are closely linked with the development of NAFLD. However, in young children, rare inborn errors of metabolism are predominant secondary causes of NAFLD. Furthermore, inborn errors of metabolism causing hepatosteatosis are often misdiagnosed as NAFLD in adolescents and adults. Many inborn errors of metabolism are treatable disorders and therefore require special consideration. This review aims to summarize the basic characteristics and diagnostic clues of inborn errors of metabolism associated with fatty liver disease. A suggested clinical and laboratory diagnostic approach is also discussed.

Indexed as

ChildChild, PreschoolDiagnosis, DifferentialFemaleHumansInfantMaleMetabolism, Inborn ErrorsNon-alcoholic Fatty Liver Disease

Identifiers

PMID32009609
PMCPMC7075690
OpenAlexW3003503734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.